Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RUFY2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | POLH | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | NSUN6 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | GOLT1B | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | TMEM14C | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | SYNPR | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | MCF2L | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | BBS9 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | SPATC1L | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | SLC29A4 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |